Study of Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation

PHASE4CompletedINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

March 31, 2011

Study Completion Date

December 31, 2012

Conditions
Atrial Fibrillation
Interventions
PROCEDURE

Atrial fibrillation ablation

"Atrial fibrillation ablation with radiofrequency, guided by 3D navigation map. Either 4mm or cooled tip-catheters will be used.~It will include, at least, pulmonary veins isolation; all other radiofrequency lines, including roof and mitral isthmus line, and complex fractioned electrograms ablation will be performed according to each Hospital protocol. Radiofrequency lines block will be tested."

DRUG

Antiarrhythmic drug

Usual drug therapy for atrial fibrillation. In patients with structural heart disease, amiodarone is recommended, while flecainide plus diltiazem or beta-blockers are encouraged in patients without structural heart diseases.

Trial Locations (8)

08036

Hospital Clinic Universitari, Barcelona

Unknown

Hospital de Sant Pau, Barcelona

Hospital de Cruces, Bilbao

Clínica Puerta de Hierro, Madrid

Hospital 12 de Octubre, Madrid

Hospital Clínico San Carlos, Madrid

Hospital Gregorio Marañon, Madrid

Hospital Ramón y Cajal, Madrid

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medtronic

INDUSTRY

collaborator

Fundacio Clinic Barcelona

OTHER

collaborator

Biosense Webster, Inc.

INDUSTRY

lead

Hospital Clinic of Barcelona

OTHER

NCT00863213 - Study of Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation | Biotech Hunter | Biotech Hunter